This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Honeywell Aerospace becomes an independent company after the June 29, 2026 spin-off, offering a focused aerospace exp...
USA Compression Partners reports record cash flow for 2025 and a path to a 1.6x-plus distribution coverage in 2026, e...
AMD and Palantir diverge in the AI rally as analysts set new price targets, outlining two distinct paths for these AI...
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
Alibaba's Qwen AI released a structured forecast for Bitcoin, Ethereum, and XRP by end-May 2026, tying targets to ETF...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
A year of unprecedented cyber thefts saw North Korean-linked groups drain more than $2 billion from financial network...
A small AI stock makes a big move. SoundHound AI just released a pivotal update that could affect its 2027 outlook an...
Analysts are shifting views on crypto firms, labeling them as core market infrastructure rather than mere tokens. The...
A new Federal Reserve chair is on the horizon, and markets are keen to know what it means for loans, mortgages, and i...